Kathleen Lehman

Pennsylvania State University, Hershey (United States), University of Maryland Medical Center

Papers

Total Citations

H-Index

About

Kathleen Lehman’s research bridges urologic oncology and radiation oncology, with a focus on optimizing surgical and radiotherapeutic approaches for cancer patients. Her most cited work investigates the feasibility of minimally invasive partial nephrectomy (MIPN) in obese patients with renal cell carcinoma, demonstrating that an obese body habitus does not preclude successful outcomes. This study, with 12 citations, challenged prevailing assumptions and expanded surgical access for a high-risk population. Lehman’s contributions extend to head and neck cancer, where she is involved in the SAVER trial, a phase I/II study exploring selective avoidance of nodal volumes in p16-positive oropharynx cancer to reduce treatment toxicity. This work, accruing 5 citations since 2024, reflects her commitment to refining cancer care through evidence-based de-escalation strategies. With a career marked by interdisciplinary collaboration and patient-centered innovation, Lehman’s research has influenced clinical practice in both kidney cancer surgery and radiation oncology. Her findings empower surgeons to offer minimally invasive options to diverse patient populations, while her ongoing work in head and neck cancer aims to preserve quality of life without compromising oncologic outcomes.